Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triheptanoin in Glut1-DS
NCT02000960Phase 2Unknown
- Sponsor
- University of British Columbia
- Start
- Apr 2014
- Primary completion
- Feb 2016
- Modality
- SLNs, Nanostructured Lipid Carriers, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of triheptanoin in Glucose Transporter Type 1 Deficiency Syndrome (Glut1DS), sponsored by University of British Columbia. Status: unknown.
02
Drugs
triheptanoin
03
Conditions
Glucose Transporter Type 1 Deficiency Syndrome (Glut1DS)
Beyond the preview
Go deeper on NCT02000960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02000960.